Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+1.81%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$6.14B
AUM Growth
+$298M
(+5.1%)
Cap. Flow
+$243M
Cap. Flow
% of AUM
3.96%
Top 10 Holdings %
Top 10 Hldgs %
20.89%
Holding
999
New
8
Increased
753
Reduced
144
Closed
14
Top Buys
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$28.2M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$22.9M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
$11.5M |
| 4 |
Equinix
EQIX
|
$10.2M |
| 5 |
Amazon
AMZN
|
$9.93M |
Top Sells
| 1 |
CME Group
CME
|
$8.52M |
| 2 |
NetApp
NTAP
|
$6.33M |
| 3 |
RHT
Red Hat Inc
RHT
|
$6.04M |
| 4 |
APC
Anadarko Petroleum
APC
|
$5.92M |
| 5 |
Align Technology
ALGN
|
$5.62M |
Sector Composition
| 1 | Technology | 18.11% |
| 2 | Financials | 13.08% |
| 3 | Healthcare | 12.29% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCE
876
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $131K | ﹤0.01% |
1,353
+237
| +21% | +$22.9K |
|
|
NOAH
877
Noah Holdings
NOAH
$819M
| $129K | ﹤0.01% |
4,424
| – | – |
|
878
Intellia Therapeutics
NTLA
$1.25B
| $128K | ﹤0.01% |
9,553
+1,859
| +24% | +$24.9K |
|
|
CUB
879
DELISTED
Cubic Corporation
CUB
| $128K | ﹤0.01% |
1,815
+46
| +3% | +$3.24K |
|
880
Toyota
TM
$258B
| $127K | ﹤0.01% |
944
+166
| +21% | +$22.3K |
|
881
Regenxbio
RGNX
$476M
| $124K | ﹤0.01% |
3,492
+686
| +24% | +$24.4K |
|
882
Fate Therapeutics
FATE
$112M
| $121K | ﹤0.01% |
7,820
+1,529
| +24% | +$23.7K |
|
|
RVI
883
DELISTED
Retail Value Inc. Common Shares
RVI
| $121K | ﹤0.01% |
35,581
| – | – |
|
884
Sanofi
SNY
$111B
| $120K | ﹤0.01% |
2,592
+394
| +18% | +$18.2K |
|
885
Telecom Argentina
TEO
$3.61B
| $120K | ﹤0.01% |
12,010
| – | – |
|
|
CIO
886
City Office REIT
CIO
$281M
| $119K | ﹤0.01% |
8,273
| – | – |
|
|
BFS
887
Saul Centers
BFS
$814M
| $117K | ﹤0.01% |
2,140
| – | – |
|
888
Q32 Bio
QTTB
$20.2M
| $117K | ﹤0.01% |
360
+62
| +21% | +$20.2K |
|
|
ASXC
889
DELISTED
Asensus Surgical, Inc.
ASXC
| $115K | ﹤0.01% |
14,321
+884
| +7% | +$7.1K |
|
|
SNR
890
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $115K | ﹤0.01% |
17,282
| – | – |
|
|
UMH
891
UMH Properties
UMH
$1.28B
| $114K | ﹤0.01% |
8,089
+1,834
| +29% | +$25.8K |
|
|
HT
892
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $114K | ﹤0.01% |
7,645
+1,396
| +22% | +$20.8K |
|
893
Novartis
NVS
$249B
| $112K | ﹤0.01% |
1,291
+192
| +17% | +$16.7K |
|
|
BLUE
894
DELISTED
bluebird bio
BLUE
| $108K | ﹤0.01% |
91
+17
| +23% | +$20.2K |
|
895
GoPro
GPRO
$231M
| $108K | ﹤0.01% |
20,746
+1,057
| +5% | +$5.5K |
|
896
Ultragenyx Pharmaceutical
RARE
$3.01B
| $108K | ﹤0.01% |
2,530
+503
| +25% | +$21.5K |
|
897
Voyager Therapeutics
VYGR
$215M
| $108K | ﹤0.01% |
6,256
+1,015
| +19% | +$17.5K |
|
898
Oceaneering
OII
$2.47B
| $107K | ﹤0.01% |
7,930
+726
| +10% | +$9.8K |
|
|
BOLD
899
DELISTED
Audentes Therapeutics, Inc
BOLD
| $107K | ﹤0.01% |
3,797
+743
| +24% | +$20.9K |
|
|
HIMX
900
Himax Technologies
HIMX
$1.45B
| $106K | ﹤0.01% |
46,778
| – | – |
|